ClinicalTrials.Veeva

Menu

Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression

U

University of Gaziantep

Status

Completed

Conditions

Migraine

Treatments

Genetic: Migraine CNV

Study type

Interventional

Funder types

Other

Identifiers

NCT04912752
2020/12

Details and patient eligibility

About

Migraine is a common and possible hereditary disease. Copy number variation (CNV) is a phenomenon in which parts of the genome are repeated and the number of repeats in the genome varies between individuals in the human population.The CHRNA7 gene has a major role in the neuropsychiatric phenotypes observed in patients. The 15q13.3 gain/loss variation in this gene may be associated with migraine.

Full description

Migraine is a common neurological disorder. Although they have different genetic bases according to their types, cholinergic receptors after calcium channels play an important role in the clinic and genetics of the disease. Neuronal acetylcholine receptor subunit alpha-7, also known as nAChRα7, is a protein that in humans is encoded by the CHRNA7 gene.

Enrollment

200 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Migraine

Exclusion criteria

Vascular problems

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

Case-Control
Other group
Description:
Copy number variation
Treatment:
Genetic: Migraine CNV
Case-Control 1
Experimental group
Description:
Gene expression
Treatment:
Genetic: Migraine CNV

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems